What Happened? Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's ...

Enter NEO, a humanoid robot created by 1X, an artificial intelligence and robotics company based in Palo Alto, California.

NeoGenomics (NEO) is still running at a loss, with losses having increased by 30% per year over the past five years and no notable rebound in profit margins. Revenue is expected to grow at 8.7% per ...

NEO will be driven by artificial intelligence, and is another example of AI beginning to integrate into people’s daily lives.

NeoGenomics (NEO) has seen its stock make some sizable moves over the past month, gaining 32% despite a more muted performance year to date. Investors appear to be reacting to a shifting outlook as ...

1X NEO is available in tan, gray and dark brown. It's now available for pre-order from the company's website with a deposit ...